• 1
    Mundy G, Garrett R, Harris S, Chan J, Chen D, Rossini G, Boyce B, Zhao M, Gutierrez G 1999 Stimulation of bone formation in vitro and in rodents by statins. Science 286: 19461949.
  • 2
    Song C, Guo Z, Ma Q, Chen Z, Liu Z, Jia H, Dang G 2003 Simvastatin induces osteoblastic differentiation and inhibits adipocytic differentiation in mouse bone marrow stromal cells. Biochem Biophys Res Commun 308: 458462.
  • 3
    Ohnaka K, Shimoda S, Nawata H, Shimokawa H, Kaibuchi K, Iwamoto Y, Takayanagi R 2001 Pitavastatin enhanced BMP-2 and osteocalcin expression by inhibition of Rho-associated kinase in human osteoblasts. Biochem Biophys Res Commun 287: 337342.
  • 4
    Sugiyama M, Kodama T, Konishi K, Abe K, Asami S, Oikawa S 2000 Compactin and simvastatin, but not pravastatin, induce bone morphogenetic protein-2 in human osteosarcoma cells. Biochem Biophys Res Commun 271: 688692.
  • 5
    Woo JT, Kasai S, Stern PH, Nagai K 2000 Compactin suppresses bone resorption by inhibiting the fusion of prefusion osteoclasts and disrupting the actin ring in osteoclasts. J Bone Miner Res 15: 650662.
  • 6
    Bauer DC 2003 HMG CoA reductase inhibitors and the skeletal: A comprehensive review. Osteoporos Int 14: 273282.
  • 7
    Chan KA, Andrade SE, Boles M, Buist DS, Chase GA, Donahue JG, Goodman MJ, Gurwitz JH, LaCroix AZ, Platt R 2000 Inhibitors of hydroxymethylglutaryl-coenzyme A reductase and risk of fracture among older women. Lancet 355: 21852188.
  • 8
    Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H 2000 Statin drugs and the risk of fracture. JAMA 284: 19211922.
  • 9
    Wang PS, Solomon DH, Mogun H, Avorn J 2000 HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients. JAMA 283: 32113216.
  • 10
    Pasco JA, Kotowicz MA, Henry MJ, Sanders KM, Nicholson GC 2002 Statin use, bone mineral density, and fracture risk: Geelong Osteoporosis Study. Arch Intern Med 162: 537540.
  • 11
    Reid IR, Hague W, Emberson J, Baker J, Tonkin A, Hunt D, MacMahon S, Sharpe N 2001 Effect of pravastatin on frequency of fracture in the LIPID study: Secondary analysis of a randomised controlled trial. Long-term intervention with pravastatin in Ischaemic disease. Lancet 357: 509512.
  • 12
    van Staa TP, Wegman S, de Vries F, Leufkens B, Cooper C 2001 Use of statins and risk of fractures. JAMA 285: 18501855.
  • 13
    Pedersen TR, Kjekshus J 2000 Statin drugs and the risk of fracture. 4S Study Group. JAMA 284: 19211922.
  • 14
    LaCroix AZ, Cauley JA, Pettinger M, Hsia J, Bauer DC, McGowan J, Chen Z, Lewis CE, McNeeley SG, Passaro MD, Jackson RD 2003 Statin use, clinical fracture, and bone density in postmenopausal women: Results from the Women's Health Initiative Observational Study. Ann Intern Med 139: 97104.
  • 15
    Funkhouser HL, Adera T, Adler RA 2002 Effect of HMG-CoA reductase inhibitors (statins) on bone mineral density. J Clin Densitom 5: 151158.
  • 16
    Sirola J, Honkanen R, Kroger H, Jurvelin JS, Maenpaa P, Saarikoski S 2002 Relation of statin use and bone loss: A prospective population-based cohort study in early postmenopausal women. Osteoporos Int 13: 537541.
  • 17
    Montagnani A, Gonnelli S, Cepollaro C, Pacini S, Campagna MS, Franci MB, Lucani B, Gennari C 2003 Effect of simvastatin treatment on bone mineral density and bone turnover in hypercholesterolemic postmenopausal women: A 1-year longitudinal study. Bone 32: 427433.
  • 18
    Edwards CJ, Hart DJ, Spector TD 2000 Oral statins and increased bone-mineral density in postmenopausal women. Lancet 355: 22182219.
  • 19
    Rejnmark L, Buus NH, Vestergaard P, Andreasen F, Larsen ML, Mosekilde L 2002 Statins decrease bone turnover in postmenopausal women: A cross-sectional study. Eur J Clin Invest 32: 581589.
  • 20
    Chung YS, Lee MD, Lee SK, Kim HM, Fitzpatrick LA 2000 HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. J Clin Endocrinol Metab 85: 11371142.
  • 21
    Wada Y, Nakamura Y, Koshiyama H 2000 Lack of positive correlation between statin use and bone mineral density in Japanese subjects with type 2 diabetes. Arch Intern Med 160: 28652870.
  • 22
    Bauer DC, Mundy GR, Jamal SA, Black DM, Cauley JA, Ensrud KE, van der Klift M, Pols HA 2004 Use of statins and fracture: Results of 4 prospective studies and cumulative meta-analysis of observational studies and controlled trials. Arch Intern Med 164: 146152.
  • 23
    Nevitt MC, Ettinger B, Black DM, Stone K, Jamal SA, Ensrud K, Segal M, Genant HK, Cummings SR 1998 The association of radiographically detected vertebral fractures with back pain and function: A prospective study. Ann Intern Med 128: 793800.
  • 24
    Ensrud KE, Thompson DE, Cauley JA, Nevitt MC, Kado DM, Hochberg MC, Santora AC II, Black DM 2000 Prevalent vertebral deformities predict mortality and hospitalization in older women with low bone mass. Fracture Intervention Trial Research Group. J Am Geriatr Soc 48: 241249.
  • 25
    Hofman A, Grobbee DE, de Jong PT, van den Ouweland FA 1991 Determinants of disease and disability in the elderly: The Rotterdam Elderly Study. Eur J Epidemiol 7: 403422.
  • 26
    World Health Organization 1992 Anatomical Therapeutic Classification (ATC) Index: Including Defined Daily Doses (DDD) for Plain Substances. WHO, Oslo, Norway.
  • 27
    Van der Klift M, De Laet CE, McCloskey EV, Hofman A, Pols HA 2002 The incidence of vertebral fractures in men and women: The Rotterdam Study. J Bone Miner Res 17: 10511056.
  • 28
    McCloskey EV, Spector TD, Eyres KS, Fern ED, O'Rourke N, Vasikaran S, Kanis JA 1993 The assessment of vertebral deformity: A method for use in population studies and clinical trials. Osteoporos Int 3: 138147.
  • 29
    Burger H, van Daele PL, Algra D, van den Ouweland FA, Grobbee DE, Hofman A, van Kuijk C, Schutte HE, Birkenhager JC, Pols HA 1994 The association between age and bone mineral density in men and women aged 55 years and over: The Rotterdam Study. Bone Miner 25: 113.
  • 30
    Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP 1983 Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum 26: 13461353.
  • 31
    Burger H, de Laet CE, van Daele PL, Weel AE, Witteman JC, Hofman A, Pols HA 1998 Risk factors for increased bone loss in an elderly population: The Rotterdam Study. Am J Epidemiol 147: 871879.
  • 32
    Folstein MF, Folstein SE, McHugh PR 1975 “Mini-mental state.” A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12: 189198.
  • 33
    Anderson KM, Odell PM, Wilson PW, Kannel WB 1991 Cardiovascular disease risk profiles. Am Heart J 121: 293298.
  • 34
    Twisk J, de Vente W 2002 Attrition in longitudinal studies. How to deal with missing data. J Clin Epidemiol 55: 329337.
  • 35
    Cooper C, Atkinson EJ, O'Fallon WM, Melton LJ III 1992 Incidence of clinically diagnosed vertebral fractures: A population-based study in Rochester, Minnesota, 1985–1989. J Bone Miner Res 7: 221227.
  • 36
    Meier CR, Schlienger RG, Kraenzlin ME, Schlegel B, Jick H 2000 HMG-CoA reductase inhibitors and the risk of fractures. JAMA 283: 32053210.